MiR-92a Promotes Cell Metastasis of Colorectal Cancer Through PTEN-Mediated PI3K/AKT Pathway

Annals of Surgical Oncology

Volumn 22, Issue 8, 2015, Pages 2649-2655

  Ke, Tao Wei ^a,b   Wei, Po Li ^d,e,f   Yeh, Ken Tu ^c   Chen, William Tzu Liang ^b   Cheng, Ya Wen ^f  

^a CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^b CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^c CHANGHUA CHRISTIAN HOSPITAL   (Taiwan)

^d TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^e TAIPEI MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^f TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ACTIN; MICRORNA; MICRORNA 92A; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN KINASE B; UNCLASSIFIED DRUG; UVOMORULIN; CADHERIN; MIRN92 MICRORNA, HUMAN; PTEN PROTEIN, HUMAN;

ADULT; AGE; AGED; ARTICLE; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CELL INVASION; CELL MIGRATION; COLORECTAL CANCER; CONTROLLED STUDY; DISEASE FREE SURVIVAL; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; SEX DIFFERENCE; UPREGULATION; CELL MOTION; COLORECTAL TUMOR; GENE SILENCING; GENETICS; METABOLISM; MIDDLE AGED; PATHOLOGY; SIGNAL TRANSDUCTION; SURVIVAL RATE; TUMOR CELL LINE;

AGED; CADHERINS; CELL LINE, TUMOR; CELL MOVEMENT; COLORECTAL NEOPLASMS; DISEASE-FREE SURVIVAL; FEMALE; GENE EXPRESSION; GENE KNOCKDOWN TECHNIQUES; HUMANS; LYMPHATIC METASTASIS; MALE; MICRORNAS; MIDDLE AGED; PHOSPHATIDYLINOSITOL 3-KINASES; PROTO-ONCOGENE PROTEINS C-AKT; PTEN PHOSPHOHYDROLASE; SIGNAL TRANSDUCTION; SURVIVAL RATE; UP-REGULATION;

EID: 84938228202     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-014-4305-2     Document Type: Article

References (22)

1. Jemal A, Siegel R, Xu J, Ward E. Cancer statistics. CA CancerJ Clin. 2010;60:277–300.
2. Leslie A, Carey FA, Pratt NR, Steele RJ. The colorectal adenoma–carcinoma sequence. Br J Surg. 2002;89:845–60.
3. Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell. 2004;116:281–97.
4. Wang H, Wu J, Meng X, et al. MicroRNA-342 inhibits colorectal cancer cell proliferation and invasion by directly targeting DNA methyltransferase 1. Carcinogenesis. 2011;32:1033–42.
5. Calin GA, Sevignani C, Dumitru CD, et al. Human micro-RNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc Natl Acad Sci U S A. 2004;101:2999–3004.
6. Shatseva T, Lee DY, Deng Z, Yang BB. MicroRNA miR-199a-3p regulates cell proliferation and survival by targeting caveolin-2. J Cell Sci. 2011;124:2826–36.
7. Hayashita Y, Osada H, Tatematsu Y, et al. A polycistronic microRNA cluster, Mir-17-92, is overexpressed in human lung cancers and enhances cell proliferation. Cancer Res. 2005;65:9628–32.
8. Shigoka M, Tsuchida A, Matsudo T, et al. Deregulation of MiR-92a expression is implicated in hepatocellular carcinoma development. Pathol Int. 2010;60:351–7.
9. Chen ZL, Zhao XH, Wang JW, et al. MicroRNA-92a promotes lymph node metastasis of human esophageal squamous cell carcinoma via E-cadherin. J Biol Chem. 2011;286:10725–34.
10. Lin HY, Chiang CH, Hung WC. STAT3 upregulates MiR-92a to inhibit RECK expression and to promote invasiveness of lung cancer cells. Br J Cancer. 2013;109:731–8.
11. Zhang G, Zhou H, Xiao H, Liu Z, Tian H, Zhou T. MicroRNA-92a functions as an oncogene in colorectal cancer by targeting PTEN.Dig Dis Sci. 2014;59:98–107.
12. Miranda E, Destro A, Malesci A, et al. Genetic and epigenetic changes in primary metastatic and nonmetastatic colorectal cancer. Br J Cancer. 2006;95:1101–7.
13. Lind GE, Thorstensen L, Løvig T, et al. A Cpg island hypermethylation profile of primary colorectal carcinomas and colon cancer cell lines. Mol Cancer. 2004;3:28.
14. Hur K, Cejas P, Feliu J, et al. Hypomethylation of long interspersed nuclear element-1 (LINE-1) leads to activation of proto-oncogenes in human colorectal cancer metastasis. Gut. 2014;63:635–46.
15. Cantley LC, Neel BG. New insights into tumor suppression; PTEN suppresses tumor formation by restraining phosphoinositide 3-kinase/Akt pathway. Proc Natl Acad Sci U S A. 1999;96:4240–5.
16. Khaleghpour K, Li Y, Banville D, et al. Involvement of PI-3 kinase signaling pathway in progression of colon adenocarcinoma. Carcinogenesis. 2004;25:241–8.
17. Stiles B, Gilman V, Khanzenzon N, et al. Essential role of Akt-1/protein kinase B in PTEN-controlled tumorigenesis. Moll Cell Biol. 2002;22:3842–51.
18. Osaki M, Oshimura M, Ito H, et al. PI3K-Akt pathway: its functions and alterations in human cancer. Apoptosis. 2004;9:667–76.
19. Colakoglu T, Yildirim S, Kayaselcuk F, et al. Clinicopathological significance of PTEN loss and the phosphoinositide 3-kinase/Akt pathway in sporadic colorectal neoplasms: is PTEN loss predictor of local recurrence? Am J Surg. 2008;195:719–25.
20. Tang JM, He QY, Guo RX, et al. Phosphorylated Akt overexpression and loss of PTEN expression in non-small lung cancer confers poor prognosis. Lung Cancer. 2006;51:181–91.
21. McMenamin ME, Soung P, Perera S, et al. Loss of PTEN expression in paraffin-embedded primary prostate cancer correlates with high Gleason score and advanced stage. Cancer Res. 1999;59:4291–6.
22. Saal LH, Holm K, Maurer M, et al. PIK3CA mutations correlate with hormone receptors, node metastasis, and ERBB2, and are mutually exclusive with PTEN loss in human breast carcinoma. Cancer Res. 2005;65:2554–9.